ABRILADA
Active substance: adalimumab-afzb
KIT · adalimumab-afzb
United StatesActive
Marketing holder: Pfizer Laboratories Div Pfizer Inc
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- adalimumab-afzb
Registration
- Registration number
- 0025-0333
- Registration status
- Active
- Dispensing
- Prescription only
Sources
- product · openFDA NDC · 0025-0333 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0025-0333 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0025-0333 · Verified 2026-10-09 · open in source